(Q80461768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Extreme drug resistance is common after prior exposure to paclitaxel (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

John P Geisler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Georgiann C Linnemeier

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Amanda J Thomas

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kelly J Manahan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

11 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

538-540

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

Hypersensitivity reactions and the utility of oral and intravenous desensitization in patients with gynecologic malignancies.

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Successful administration of carboplatin in patients with clinically documented carboplatin hypersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

A phase I trial of prolonged oral etoposide and liposomal doxorubicin in ovarian, peritoneal, and tubal carcinoma: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Treatment of recurrent ovarian cancer: a retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

In vitro chemosensitivity testing and mechanisms of drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2007.05.002

10.1016/J.YGYNO.2007.05.002

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17561236%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference